Cannabis M&A Surge Accelerates: High Tide and Canopy Growth Lead Industry Consolidation episode artwork

EPISODE · Mar 30, 2026 · 2 MIN

Cannabis M&A Surge Accelerates: High Tide and Canopy Growth Lead Industry Consolidation

from Cannabis Industry News · host Inception Point AI

In the past 48 hours, the cannabis industry shows robust merger and acquisition activity amid steady stock trading, with no major regulatory shifts or disruptions reported. Canopy Growth secured shareholder approval for its MTL Cannabis acquisition, expected to close by end of March 2026, bolstering its Canadian footprint[6]. High Tide closed a 51 percent stake in German firm Remexian Pharma for 26.4 million euros, with an option for the rest, positioning it as a key player in Europe's medical cannabis market; a separate 27.2 million euro deal further expands there[6]. Other moves include Curio Wellness buying four Missouri dispensaries, Raw Garden acquiring California Love for clean cannabis growth, Vireo Growth taking Schwazze notes, InterCure snapping up US-tech firm ISHI, LEVIA founders reclaiming their beverage brand from Ayr Wellness, Standard Wellness adding an Ohio store for 1.35 million dollars, and Agrify purchasing Green Thumb's RYTHM portfolio for 50 million dollars, including Dogwalkers and Beboe brands[6]. Tilray Brands, Canopy Growth, Aurora Cannabis, SNDL, Cronos Group, Quantum Biopharma, and High Tide led trading volume on March 29, signaling investor focus on top performers despite flat prices[4]. Cresco Labs announced its California exit, divesting assets in a restructuring, while Curaleaf bought out its European minority partner for full control[6]. No new product launches or consumer behavior shifts surfaced, though vape deals persist in Denver[8]. Hemp raids in Kansas drew lawsuits, hinting at regulatory tension[9]. Compared to prior weeks, M&A pace accelerates versus First Citizens' February 2026 report on industry banking strains[10], with leaders like High Tide responding aggressively to international growth challenges. Trading remains stable, lacking the volatility of early 2026 tax reform talks[4]. Overall, consolidation drives resilience in a maturing market. (298 words) For great deals today, check out https://amzn.to/44ci4hQ This content was created in partnership and with the help of Artificial Intelligence AI.

In the past 48 hours, the cannabis industry shows robust merger and acquisition activity amid steady stock trading, with no major regulatory shifts or disruptions reported. Canopy Growth secured shareholder approval for its MTL Cannabis acquisition, expected to close by end of March 2026, bolstering its Canadian footprint[6]. High Tide closed a 51 percent stake in German firm Remexian Pharma for 26.4 million euros, with an option for the rest, positioning it as a key player in Europe's medical cannabis market; a separate 27.2 million euro deal further expands there[6]. Other moves include Curio Wellness buying four Missouri dispensaries, Raw Garden acquiring California Love for clean cannabis growth, Vireo Growth taking Schwazze notes, InterCure snapping up US-tech firm ISHI, LEVIA founders reclaiming their beverage brand from Ayr Wellness, Standard Wellness adding an Ohio store for 1.35 million dollars, and Agrify purchasing Green Thumb's RYTHM portfolio for 50 million dollars, including Dogwalkers and Beboe brands[6]. Tilray Brands, Canopy Growth, Aurora Cannabis, SNDL, Cronos Group, Quantum Biopharma, and High Tide led trading volume on March 29, signaling investor focus on top performers despite flat prices[4]. Cresco Labs announced its California exit, divesting assets in a restructuring, while Curaleaf bought out its European minority partner for full control[6]. No new product launches or consumer behavior shifts surfaced, though vape deals persist in Denver[8]. Hemp raids in Kansas drew lawsuits, hinting at regulatory tension[9]. Compared to prior weeks, M&A pace accelerates versus First Citizens' February 2026 report on industry banking strains[10], with leaders like High Tide responding aggressively to international growth challenges. Trading remains stable, lacking the volatility of early 2026 tax reform talks[4]. Overall, consolidation drives resilience in a maturing market. (298 words) For great deals today, check out https://amzn.to/44ci4hQ This content was created in partnership and with the help of Artificial Intelligence AI.

NOW PLAYING

Cannabis M&A Surge Accelerates: High Tide and Canopy Growth Lead Industry Consolidation

0:00 2:21

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabis Industry News?

This episode is 2 minutes long.

When was this Cannabis Industry News episode published?

This episode was published on March 30, 2026.

What is this episode about?

In the past 48 hours, the cannabis industry shows robust merger and acquisition activity amid steady stock trading, with no major regulatory shifts or disruptions reported. Canopy Growth secured shareholder approval for its MTL Cannabis acquisition,...

Can I download this Cannabis Industry News episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!